Sign In
By signing in or creating an account, you agree with Associated Broadcasting Company's Terms & Conditions and Privacy Policy.
By signing in or creating an account, you agree with Associated Broadcasting Company's Terms & Conditions and Privacy Policy.
Kolkata: At the end of the second day of bidding on Nov 24, Sudeep Pharma IPO was subscribed 5.13 times overall -- 5.02 times in the retail category, 0.13 times in QIB (Ex Anchor) category and 12.03 times in the NII category. The public issue was fully subscribed on the first day of bidding when it attracted bids worth 1.43 times overall and 1.53 times in the retail category. The IPO is designed to mop up Rs 895 crore through a combination fresh issue of 0.16 crore shares aggregating to Rs 95 crores and an OFS part to raise Rs 800 crores.
Sudeep Pharma is a Gujarat-based pharmaceutical company which is entrenched in the manufacture of pharmaceutical excipients, food-grade minerals and specialty nutrition ingredients. It boasts of customers that are spread over more than 100 countries. Among its clints are Pfizer Inc., Mankind Pharma, Merck Group, Aurobindo Pharma, Cadila Pharmaceutical, IMCD Asia Pte Ltd and Danone SA. The prospectus says it will use the proceeds of the sale of fresh shares for purchase of machinery and general corporate purposes.
Sudeep Pharma had significant success in the anchor round of investment when it mobilized Rs 268.5 crore from anchor investors. Among them were AMCs such as SBI Mutual Fund (MF), HDFC MF, ICICI Prudential MF, Nippon India MF, WhiteOak Capital MF, Aditya Birla Sun Life MF, Motilal Oswal MF, Quant MF, Bandhan MF, UTI MF, Edelweiss MF, Tata AIA Life Insurance and SBI Life Insurance. The company allocated 45,27,823 equity shares at Rs 593 per share to anchor investors.
Sudeep Pharma IPO GMP
According to investorgain, Sudeep Pharma IPO GMP stood at Rs 90 in earl morning of Nov 25, the last day of the bidding process. It has an upper price of R 593.00 and therefore, the listing price is Rs and the listing gain could be 15.18%. The GP has actually crawled down from Rs 115 on No 21, the first day of bidding. However, it must be remembered that GMP is an unofficial indicator, is extremely volatile and cannot guarantee listing gain or loss.
Sudeep Pharma IPO price band, lot size, key dates
Sudeep Pharma IPO price band is Rs 563-593. A retail investor has to bid for a minimum lot has of 25 shares for which he/she has to pay an application money of Rs 14,825 based on the upper end of the price band. On the other hand, the minimum investible lot for sNII investors is 350 shares, while the minimum lot for bNII category of investors is 1,700 shares. ICICI Securities is the lead manager and MUFG Intime India the registrar for the issue.
IPO closes: Today, Nov 25, 2025
Allotment: Nov 26
Refund: Nov 27
Credit of shares to demat: Nov 27
Listing: Nov 28
Cut-off time for UPI mandate confirmation: 5 pm on Nov 25
(Disclaimer: This article is only meant to provide information. TV9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, precious metals, commodity, REITs, INVITs, any form of alternative investment instruments and crypto assets.)
